Remarkable Response to Etoposide and Cisplatin in Aggressive-Variant Prostate Cancer With Low Prostate-Specific Antigen Levels: A Case Report.

Saved in:
Bibliographic Details
Title: Remarkable Response to Etoposide and Cisplatin in Aggressive-Variant Prostate Cancer With Low Prostate-Specific Antigen Levels: A Case Report.
Authors: Ikeda J; Urology and Andrology, Kansai Medical University, Hirakata, JPN., Taniguchi H; Urology and Andrology, Kansai Medical University, Hirakata, JPN., Inoue M; Urology and Andrology, Kansai Medical University, Hirakata, JPN., Masuo Y; Urology and Andrology, Kansai Medical University, Hirakata, JPN., Nakamoto T; Urology and Andrology, Kansai Medical University, Hirakata, JPN., Yanishi M; Urology and Andrology, Kansai Medical University, Hirakata, JPN., Uchida K; Pathology, Kansai Medical University, Hirakata, JPN., Kinoshita H; Urology and Andrology, Kansai Medical University, Hirakata, JPN.
Source: Cureus [Cureus] 2026 Jan 03; Vol. 18 (1), pp. e100713. Date of Electronic Publication: 2026 Jan 03 (Print Publication: 2026).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first